![NCI requests $7.8B for FY2023 to increase R01 paylines to 13th percentile](https://cdn.cancerletter.com/media/2021/09/10154841/47-33-paylines-4x3-1.jpg)
![NCI requests $7.8B for FY2023 to increase R01 paylines to 13th percentile](https://cdn.cancerletter.com/media/2021/09/10154841/47-33-paylines-4x3-1.jpg)
Cover Story
NCI Director's Report
NCI is asking for an appropriation of $7.8 billion for fiscal year 2023—about $800 million above the House’s FY22 proposed budget for NCI.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa
- A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities